HQH
abrdn Healthcare InvestorsHQH
HQH
About: abrdn Healthcare Investors Formerly Tekla Healthcare Investors is the United States based non-diversified closed-end management investment company. Its objective is to seek long-term capital appreciation by investing in securities of healthcare companies. In addition, the fund seeks to provide regular distribution of realized capital gains. The fund invests in the securities of public and private companies.
0
Funds holding %
of 7,310 funds
–
Analysts bullish %
Fund manager confidence
Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)
71% more repeat investments, than reductions
Existing positions increased: 41 | Existing positions reduced: 24
0.9% less ownership
Funds ownership: 25.0% [Q4 2024] → 24.1% (-0.9%) [Q1 2025]
3% less capital invested
Capital invested by funds: $194M [Q4 2024] → $189M (-$4.88M) [Q1 2025]
12% less funds holding
Funds holding: 116 [Q4 2024] → 102 (-14) [Q1 2025]
39% less first-time investments, than exits
New positions opened: 14 | Existing positions closed: 23
Research analyst outlook
We haven’t received any recent analyst ratings for HQH.
Financial journalist opinion
Based on 4 articles about HQH published over the past 30 days
Negative
Seeking Alpha
5 hours ago
High Risk, Low Return: The Problem With HQH's Biotech Tilt
HQH offers high yields with a biotech and small/mid-cap tilt, but relies on capital payouts, making it less tax-efficient and more volatile. Active management and venture capital-style investing add agility but increase risk, with portfolio holdings changing frequently and a heavy biotech concentration. Total returns have been uninspiring, with NAV erosion, funding payouts, and sector underperformance, especially compared to broader healthcare funds like BME.
Positive
Seeking Alpha
9 hours ago
2 Healthcare Picks For Distributions And Attractive Valuations
Healthcare CEFs are under pressure from regulatory shifts, but sector defensiveness and discounted valuations can create long-term opportunities. Within the CEF structure, we also have the added benefit that comes with the discount/premium dynamic inherent in the structure. We are looking at two names today that present investors with attractive distributions and that are looking like decently discounted opportunities.
Neutral
PRNewsWire
1 day ago
ABERDEEN INVESTMENTS U.S. CLOSED-END FUNDS ANNOUNCE DISTRIBUTION PAYMENT DETAILS
PHILADELPHIA , June 30, 2025 /PRNewswire/ -- The Aberdeen Investments U.S. Closed-End Funds (NYSE: ASGI, HQH, HQL, IFN, THQ), (NYSE American: IAF) (the "Funds" or individually the "Fund"), today announced that the Funds paid the distributions noted in the table below on June 30, 2025, on a per share basis to all shareholders of record as of June 23, 2025 (ex-dividend date June 23, 2025). These dates apply to the Funds listed below with the exception of abrdn Healthcare Investors (HQH), abrdn Life Sciences Investors (HQL), abrdn Australia Equity Fund, Inc. (IAF) and the India Fund Inc. (IFN) which paid on June 30, 2025, to all shareholders of record as of May 22, 2025 (ex-dividend date May 22, 2025).
Positive
Seeking Alpha
1 week ago
CEF Insights: The Future Of Healthcare Investing
Groundbreaking AI-powered initiatives are set to transform the healthcare landscape, potentially revolutionizing cancer research and healthcare investing. Aberdeen Investments' four healthcare-focused closed-end funds meet various investor needs: THQ/THW for income and stability, HQH/HQL for growth and innovation exposure. Jason Akus, Portfolio Manager and Head of Healthcare Investments with Aberdeen Investments, gives insight into how new innovations may impact investment opportunities.
Positive
Seeking Alpha
1 month ago
HQH: Efficient Fund To Collect Income From Healthcare
I maintain my buy rating on HQH for its high 13.6% yield, strong dividend coverage, and efficient healthcare sector diversification. HQH trades at an 8% discount to NAV, offering an attractive entry point compared to peers, despite recent price declines. The fund is well-positioned to benefit from long-term healthcare sector growth, driven by rising spending and health-conscious trends.
Neutral
Seeking Alpha
1 month ago
HQH: A Good Balance Of Returns And Risks In The Healthcare Sector
HQH offers a compelling mix of high yield and growth exposure to healthcare, trading at a discount to NAV with recent outperformance versus benchmarks. The fund benefits from strong healthcare industry tailwinds—aging populations and innovation—while active management and share buybacks support narrowing the NAV discount. A robust 13.6% market yield and a fair value estimate 36% above current price highlight significant upside, though distribution sustainability must be monitored.
Positive
Seeking Alpha
1 month ago
2 Fat Dividends For A Lifetime Of Passive Income
Berkshire Hathaway's portfolio of cash flow generators allows financial independence and opportunistic moves without financing dependencies. The "Income Method" aims to replicate Mr. Buffett's financial independence by prioritizing the generation of income streams from our personal portfolios. We discuss our top picks with yields of up to 15%.
Positive
Seeking Alpha
2 months ago
8 Closed-End Fund Buys (And 2 Sells) In The Month Of March 2025
This month we got some increased market volatility, allowing me to put some of my cash pile to work in my closed-end fund portfolio. I also sold out of two positions, as they were starting to become on the more expensive side in terms of discounts/premiums. Adding to my positions regularly every month increases my cash flow annually, and even every month it grows.
Positive
Seeking Alpha
4 months ago
Bargain Alert: 2 Big Dividends, Up To 10% Yield
Immunize your retirement from market noise with recurring dividends. We discuss two essential sectors for reliable income generation, regardless of economic conditions. Discover our top picks with up to 10% yields.
Positive
Seeking Alpha
4 months ago
I Am Loading Up Big Dividends For My Golden Years
Innovation, demand, and shortage of providers have kept healthcare inflation significantly higher than the CPI. Regardless of the political scene, the aging U.S. population and rising chronic illnesses are undeniable truths to face. Income investing ensures consistent returns, allowing flexibility in financial planning, despite volatile stock prices.
Charts implemented using Lightweight Charts™